Artivion (AORT) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,250.00 |
| Dec 31, 2025 | -300.00 |
| Sep 30, 2025 | -274.00 |
| Jun 30, 2025 | 1,376.00 |
| Mar 31, 2025 | 2,264.00 |
| Dec 31, 2024 | -4,081.00 |
| Sep 30, 2024 | 1,623.00 |
| Jun 30, 2024 | -1,272.00 |
| Mar 31, 2024 | 1,220.00 |
| Dec 31, 2023 | 1,080.00 |
| Sep 30, 2023 | -1,849.00 |
| Jun 30, 2023 | 1,510.00 |
| Mar 31, 2023 | -1,722.00 |
| Dec 31, 2022 | 3,510.00 |
| Sep 30, 2022 | -4,334.00 |
| Jun 30, 2022 | -3,060.00 |
| Mar 31, 2022 | -1,474.00 |
| Dec 31, 2021 | -3,741.00 |
| Sep 30, 2021 | 117.00 |
| Jun 30, 2021 | -324.00 |
| Mar 31, 2021 | -2,457.00 |
| Dec 31, 2020 | -232.00 |
| Sep 30, 2020 | 405.00 |
| Jun 30, 2020 | 184.00 |
| Mar 31, 2020 | -1,560.00 |
| Dec 31, 2019 | 341.00 |
| Sep 30, 2019 | -1,807.00 |
| Jun 30, 2019 | 184.00 |
| Mar 31, 2019 | -891.00 |
| Dec 31, 2018 | -3,074.00 |
| Sep 30, 2018 | -716.00 |
| Jun 30, 2018 | -2,233.00 |
| Mar 31, 2018 | -77.00 |
| Dec 31, 2017 | -863.00 |
| Sep 30, 2017 | -116.00 |
| Jun 30, 2017 | -318.00 |
| Mar 31, 2017 | 238.00 |
| Dec 31, 2016 | 46.00 |
| Sep 30, 2016 | -25.00 |
| Jun 30, 2016 | -189.00 |
| Mar 31, 2016 | 11.00 |
| Dec 31, 2015 | -20.00 |
| Sep 30, 2015 | 1,555.00 |
| Jun 30, 2015 | -1,045.00 |